These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12684572)

  • 1. [The bank of biological material in the SU.VI.MAX study].
    Galan P; Favier A; Preziosi P; Bertrais S; Arnault N; Hercberg S
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):147-50. PubMed ID: 12684572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study.
    Hercberg S; Galan P; Preziosi P; Roussel AM; Arnaud J; Richard MJ; Malvy D; Paul-Dauphin A; Briançon S; Favier A
    Int J Vitam Nutr Res; 1998; 68(1):3-20. PubMed ID: 9503043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
    Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
    Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antioxidant micronutrients and chronic degenerative pathology: the role of complementary nutritional doses].
    Hercberg S
    Bull Mem Acad R Med Belg; 1997; 152(10-11):379-85; discussion 385-7. PubMed ID: 9627441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fibre intake and clinical indices in the French Supplementation en Vitamines et Minéraux AntioXydants (SU.VI.MAX) adult cohort.
    Lairon D; Bertrais S; Vincent S; Arnault N; Galan P; Boutron MC; Hercberg S;
    Proc Nutr Soc; 2003 Feb; 62(1):11-5. PubMed ID: 12740051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants.
    Hercberg S; Preziosi P; Galan P; Faure H; Arnaud J; Duport N; Malvy D; Roussel AM; Briançon S; Favier A
    Food Chem Toxicol; 1999; 37(9-10):925-30. PubMed ID: 10541446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants.
    Hercberg S; Preziosi P; Briançon S; Galan P; Triol I; Malvy D; Roussel AM; Favier A
    Control Clin Trials; 1998 Aug; 19(4):336-51. PubMed ID: 9683310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX study.
    Bruckert E; Czernichow S; Bertrais S; Paillard F; Tichet J; Galan P; Castetbon K; Hercberg S
    Prev Med; 2005 Jun; 40(6):803-11. PubMed ID: 15850882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial.
    Faure H; Preziosi P; Roussel AM; Bertrais S; Galan P; Hercberg S; Favier A
    Eur J Clin Nutr; 2006 Jun; 60(6):706-17. PubMed ID: 16391586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The SUVIMAX (France) study: the role of antioxidants in the prevention of cancer and cardiovascular disorders].
    Vázquez Martínez C; Galán P; Preziosi P; Ribas L; Serra LL; Hercberg S
    Rev Esp Salud Publica; 1998; 72(3):173-83. PubMed ID: 9810825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological banks of the prospective cohort PRIME Study].
    Luc G; Ferri res J; Evans A; Amouyel P; Arveiler D; Cambien F; Fruchart JC; Ducimetière P;
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):159-66. PubMed ID: 12684574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antioxidant supplements and risk of hypertension in the SU.VI.MAX trial: relationship to plasma antioxidants].
    Czernichow S; Bertrais S; Blacher J; Galan P; Briançon S; Favier A; Safar M; Hercberg S
    Arch Mal Coeur Vaiss; 2006; 99(7-8):665-8. PubMed ID: 17061440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SU.VI.MAX trial on antioxidants.
    Hercberg S; Galan P; Preziosi P; Malvy M; Briançon S; Ait HM; Rahim B; Favier A
    IARC Sci Publ; 2002; 156():451-5. PubMed ID: 12484233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of the bank of biological material in the hospital-based SEROCO and HEMOCO cohorts of HIV-infected patients].
    Meyer L; Gharib M; Lerable J; Sarr A; Boufassa F; Deveau C; Boucherit S; Chaib A; Hubert JB; Persoz A; Delfraissy JF; Rouzioux C
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):151-8. PubMed ID: 12684573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 6-year body weight change on cardiac geometry and function in ageing adults: the SUpplémentation en Vitamines et Minéraux AntioXydants -2 (SU.VI.MAX-2) cardiovascular ultrasound substudy.
    Monsuez JJ; Kesse-Guyot E; Fezeu L; Blacher J; Galan P; Sebbane G; Hercberg S; Czernichow S
    J Hypertens; 2010 Nov; 28(11):2309-15. PubMed ID: 20706135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
    Hercberg S; Galan P; Preziosi P; Bertrais S; Mennen L; Malvy D; Roussel AM; Favier A; Briançon S
    Arch Intern Med; 2004 Nov; 164(21):2335-42. PubMed ID: 15557412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Constitution of a bank of biological material in the French Gazel cohort: logistical and practical aspects].
    Zins M; Ozguler A; Bonenfant S; Henny J; Goldberg M
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):143-6. PubMed ID: 12684571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity does not influence the effect of antioxidant supplementation at nutritional doses on the incidence of impaired fasting glucose: a 7.5 year post-hoc analysis from the SU.VI.MAX study.
    Fezeu L; Henegar A; Kesse-Guyot E; Julia C; Galan P; Hercberg S; Ristow M; Czernichow S
    Horm Metab Res; 2010 Oct; 42(11):826-7. PubMed ID: 20665424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study.
    Hercberg S; Czernichow S; Galan P
    Br J Nutr; 2006 Aug; 96 Suppl 1():S28-30. PubMed ID: 16923246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.